Chen YC - Search Results

1

Is ypTNM staging a comparable predictor as pTNM staging for survival in non-metastatic rectal cancer after preoperative chemoradiation therapy?

Chuang JP, Tsai HL, Su WC, Chen PJ, Huang CW, Chang TK, Chen YC, Li CC, Yeh YS, Yin TC, Wang JY. Chuang JP, et al. Among authors: chen pj, chen yc. Oncol Res. 2024 Oct 16;32(11):1723-1732. doi: 10.32604/or.2024.052098. eCollection 2024. Oncol Res. 2024. PMID: 39449806 Free PMC article.

2

Observational Study Comparing Efficacy and Safety between Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy for Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer.

Yeh YS, Huang MY, Ma CJ, Huang CW, Tsai HL, Chen YC, Li CC, Yu FJ, Shih HY, Wang JY. Yeh YS, et al. Among authors: chen yc. J Oncol. 2020 Sep 7;2020:6931317. doi: 10.1155/2020/6931317. eCollection 2020. J Oncol. 2020. PMID: 32963531 Free PMC article.

3

Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I-III rectal cancer undergoing preoperative chemoradiotherapy.

Huang CW, Su WC, Yin TC, Chen PJ, Chang TK, Chen YC, Li CC, Hsieh YC, Tsai HL, Wang JY. Huang CW, et al. Among authors: chen pj, chen yc. PLoS One. 2020 Oct 16;15(10):e0240742. doi: 10.1371/journal.pone.0240742. eCollection 2020. PLoS One. 2020. PMID: 33064768 Free PMC article.

4

Oncological Outcomes of Robotic-Assisted Surgery With High Dissection and Selective Ligation Technique for Sigmoid Colon and Rectal Cancer.

Yin TC, Su WC, Chen PJ, Chang TK, Chen YC, Li CC, Hsieh YC, Tsai HL, Huang CW, Wang JY. Yin TC, et al. Among authors: chen pj, chen yc. Front Oncol. 2020 Oct 21;10:570376. doi: 10.3389/fonc.2020.570376. eCollection 2020. Front Oncol. 2020. PMID: 33194663 Free PMC article.

5

Impact of previous abdominal surgery on robotic-assisted rectal surgery in patients with locally advanced rectal adenocarcinoma: a propensity score matching study.

Huang CW, Su WC, Chang TK, Ma CJ, Yin TC, Tsai HL, Chen PJ, Chen YC, Li CC, Hsieh YC, Wang JY. Huang CW, et al. Among authors: chen pj, chen yc. World J Surg Oncol. 2020 Nov 25;18(1):308. doi: 10.1186/s12957-020-02086-1. World J Surg Oncol. 2020. PMID: 33239020 Free PMC article.

6

Oncological outcomes of robotic-assisted total mesorectal excision after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.

Chen PJ, Su WC, Chang TK, Chen YC, Li CC, Yin TC, Tsai HL, Ma CJ, Huang CW, Wang JY. Chen PJ, et al. Among authors: chen yc. Asian J Surg. 2021 Jul;44(7):957-963. doi: 10.1016/j.asjsur.2021.01.018. Epub 2021 Feb 20. Asian J Surg. 2021. PMID: 33622595 Free article.

7

UGT1A1 Polymorphism for Irinotecan Dose Escalation in Patients with BRAF-Mutated Metastatic Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI.

Hsieh YC, Chang TK, Su WC, Huang CW, Tsai HL, Chen YC, Li CC, Chen PJ, Yin TC, Ma CJ, Wang JY. Hsieh YC, et al. Among authors: chen yc, chen pj. J Oncol. 2021 Mar 9;2021:6686517. doi: 10.1155/2021/6686517. eCollection 2021. J Oncol. 2021. PMID: 33777142 Free PMC article.

8

A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab.

Chang TK, Yin TC, Su WC, Tsai HL, Huang CW, Chen YC, Li CC, Chen PJ, Ma CJ, Chuang KH, Cheng TL, Wang JY. Chang TK, et al. Among authors: chen yc, chen pj. Oncol Res. 2021 Sep 7;28(7):801-809. doi: 10.3727/096504021X16218531628569. Epub 2021 May 24. Oncol Res. 2021. PMID: 34030768 Free PMC article. Clinical Trial.

9

Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer.

Chen YC, Tsai HL, Li CC, Huang CW, Chang TK, Su WC, Chen PJ, Yin TC, Huang CM, Wang JY. Chen YC, et al. Among authors: chen pj. PLoS One. 2021 Nov 2;16(11):e0259460. doi: 10.1371/journal.pone.0259460. eCollection 2021. PLoS One. 2021. PMID: 34727133 Free PMC article.

10

Comparison of UGT1A1 Polymorphism as Guidance of Irinotecan Dose Escalation in RAS Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIRI as the First-Line Therapy.

Tsai HL, Chen YC, Yin TC, Su WC, Chen PJ, Chang TK, Li CC, Huang CW, Wang JY. Tsai HL, et al. Among authors: chen yc, chen pj. Oncol Res. 2022 May 4;29(1):47-61. doi: 10.3727/096504022X16451187313084. Epub 2022 Feb 17. Oncol Res. 2022. PMID: 35177165 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,039 results

Search Page

Filters